[조사자료] 세계의 원료 의약품 (API) 시장 2024-2030 : 합성 유형별 (바이오, 합성), 제조업체 유형별 (자체 생산, 외부 판매), 종류별, 용도별, 의약품 유형별, 지역별

■ 영문 제목 : Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Type Of Drug, By Region, And Segment Forecasts, 2024 - 2030
	■ 상품코드 : GRV24JAN159 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 11월 ■ 페이지수 : 191 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,330,000	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,730,000	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,530,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 원료 의약품 (API) 시장의 성장과 동향
Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 원료 의약품 (API) 시장 규모는 2024년부터 2030년까지 연평균 성장률(CAGR) 5.75%로 성장해 2030년 3,529억 8,000만 달러 규모에 이를 것으로 예상됩니다. 바이오 의약품 분야의 성장, 원료 의약품 (API) 제조의 발전, 고령 인구의 증가가 시장을 견인할 것으로 보입니다.

캡티브 API 부문의 성장은 기업들이 API 자체 생산을 위한 문제 해결과 새로운 화학적 방법 개발에 투자함으로써 주도하고 있습니다. 이는 비용과 오염 위험을 줄이는 데 도움이 됩니다. 인공지능과 단백질 합성은 공정의 통제력을 높이고 더 빠른 개발을 촉진할 것으로 예상됩니다.

심혈관 질환과 같은 만성 질환과 생활습관병의 유병률 증가는 API에 대한 수요를 가속화하고 있습니다. 예를 들어, 2020년 미국 약사에 따르면 성인의 47%가 심혈관 질환 발병을 지원하는 위험 요인을 하나 이상 가지고 있다고 합니다. 심혈관 질환은 전 세계적으로 중요한 공중 보건 부담 중 하나이며, 이 분야의 활성 제약 성분 (API)에 대한 광범위한 연구 개발을 주도하고 있습니다.

원료 의약품 (API) 시장은 코로나19 팬데믹으로 인해 긍정적인 영향을 받았습니다. 전염병의 결과로 제약 회사는 더 많은 환자 집단에 초점을 맞추기 위해 전략을 변경했습니다. 예를 들어, 미국은 코로나 바이러스 치료를 위해 인도에서 HCQ를 수입하도록 요청했습니다. 이 바이러스는 캐나다의 의약품 공급 시스템에도 영향을 미쳐 환자에게 합병증을 유발할 수 있습니다. 제네릭 의약품의 중요성 증가, 바이오 의약품 소비 증가, 의약품 제조를 위한 의약품 연구 개발 활동의 확대는 시장 성장을 촉진하는 주요 요인입니다. 그러나 일부 국가의 불리한 약가 관리 제도와 높은 제조 비용은 시장 확대에 걸림돌이 될 수 있습니다.

인도와 같은 개발도상국은 지정학적 상황으로 인해 중국과 같은 API 시장을 지배하는 국가들보다 시장에서 선호되고 있습니다. 또한, 인도는 양질의 원료와 제품, 대규모 노동력, 방대한 유통망, 'Make in India' 프로그램을 통한 정부 보조금 등을 보유하고 있습니다.

미충족 의료 수요에 대응하기 위해 기업들은 공동으로 새로운 치료법을 개발하고 있습니다. 2021년 11월, 머크(Merck & Co Inc.)는 Acceleron Pharma를 인수했다고 발표하며, 이를 통해 기업들은 자사의 자원을 제품 개발에 활용하고 공급망을 강화할 수 있게 되었습니다. 이번 인수는 Merck & Co의 심혈관 포트폴리오와 파이프라인을 확장하는 데 도움이 될 것으로 보입니다.

원료 의약품 (API) 시장 보고서 하이라이트

- 신약 개발을 위한 R&D 활동의 증가와 정부의 적극적인 노력으로 혁신적인 API가 2023년 62.0%로 가장 큰 점유율을 차지할 것으로 예상됩니다.

- 캡티브 API 부문은 2023년 51.03%로 가장 큰 점유율을 차지할 것으로 예상됩니다.

- 합성 의약품 활성 성분(API) 부문은 2023년 70.66%의 최대 매출 점유율로 시장을 지배했습니다.

- 북미는 2023년 38.26%의 최대 매출 점유율을 차지하며 예측 기간 동안 선두를 유지할 것으로 예상됩니다. 이는 다른 생활습관병과 함께 암의 역학이 증가함에 따라 연구 개발 활동이 촉진되어 시장 성장을 촉진하고 있기 때문입니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 원료 의약품 (API) 시장 변수/동향/범위
4. 종합 비즈니스 분석
5. 세계의 원료 의약품 (API) 시장 규모 : 제조 업체 유형별 비즈니스 분석
6. 세계의 원료 의약품 (API) 시장 규모 : 유형별 비즈니스 분석
7. 세계의 원료 의약품 (API) 시장 규모 : 용도별 비즈니스 분석
8. 세계의 원료 의약품 (API) 시장 규모 : 의약품별 사업 유형별 분석
9. 세계의 원료 의약품 (API) 시장 규모 : 지역별 비즈니스 분석
10. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective – 1
1.2.2. Objective – 2
1.2.3. Objective – 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Gvr’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers
3.4.1. Increasing geriatric population
3.4.2. Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
3.4.3. Increasing preference for targeted therapy approach in cancer treatment
3.4.4. Increasing preference for outsourcing APIs
3.5. Market Restraint Analysis
3.5.1. High capital investments and production cost
3.5.2. Stringent Safety and handling regulations regarding APIs
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Type of Synthesis Business Analysis
4.1. Active Pharmaceutical Ingredients Market: Type of Synthesis Movement Analysis
4.2. Biotic APIs
4.2.1. Biotic APIs Market, 2018 – 2030 (USD Billion)
4.2.1.1. Biotech APIs Market, By Type (Revenue, USD Billion, 2018 – 2030)
4.2.1.2. Generic APIs
4.2.1.2.1. Generic APIs Market, 2018 – 2030 (USD Billion)
4.2.1.3. Innovative APIs
4.2.1.3.1. Innovative APIs Market, 2018 – 2030 (USD Billion)
4.2.1.4. Biotech APIs Market, By Product (Revenue, USD Billion, 2018 – 2030)
4.2.1.5. Monoclonal Antibodies
4.2.1.5.1. Monoclonal Antibodies Market, 2018 – 2030 (USD Billion)
4.2.1.6. Hormones
4.2.1.6.1. Hormones Market, 2018 – 2030 (USD Billion)
4.2.1.7. Cytokines
4.2.1.7.1. Cytokines Market, 2018 – 2030 (USD Billion)
4.2.1.8. Recombinant Proteins
4.2.1.8.1. Recombinant Proteins Market, 2018 – 2030 (USD Billion)
4.2.1.9. Therapeutic Enzymes
4.2.1.9.1. Therapeutic Enzymes Market, 2018 – 2030 (USD Billion)
4.2.1.10. Vaccines
4.2.1.10.1. Vaccines Market, 2018 – 2030 (USD Billion)
4.2.1.11. Blood Factors
4.2.1.11.1. Blood Factors Market, 2018 – 2030 (USD Billion)
4.3. Synthetic APIs
4.3.1. Synthetic APIs Market, 2018 – 2030 (USD Billion)
4.3.1.1. Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 – 2030)
4.3.1.2. Generic APIs
4.3.1.2.1. Generic APIs Market, 2018 – 2030 (USD Billion)
4.3.1.3. Innovative APIs
4.3.1.3.1. Innovative APIs Market, 2018 – 2030 (USD Billion)
Chapter 5. Type of Manufacturer Business Analysis
5.1. Active Pharmaceutical Ingredients Market: Type of Manufacturer Movement Analysis
5.2. Captive APIs
5.2.1. Captive APIs Market, 2018 – 2030 (USD Billion)
5.3. Merchant APIs
5.3.1. Merchant APIs Market, 2018 – 2030 (USD Billion)
Chapter 6. Type Business Analysis
6.1. Active Pharmaceutical Ingredients Market: Type Movement Analysis
6.2. Generic APIs
6.2.1. Generic APIs Market, 2018 – 2030 (USD Billion)
6.3. Innovative APIs
6.3.1. Innovative APIs Market, 2018 – 2030 (USD Billion)
Chapter 7. Application Business Analysis
7.1. Active Pharmaceutical Ingredients Market: Application Movement Analysis
7.2. Cardiovascular Diseases
7.2.1. Cardiovascular Diseases Market, 2018 – 2030 (USD Billion)
7.3. Oncology
7.3.1. Innovative APIs Oncology Market, 2018 – 2030 (USD Billion)
7.4. CNS and Neurology
7.4.1. CNS and Neurology Market, 2018 – 2030 (USD Billion)
7.5. Orthopedic
7.5.1. Orthopedic Market, 2018 – 2030 (USD Billion)
7.6. Endocrinology
7.6.1. Endocrinology Market, 2018 – 2030 (USD Billion)
7.7. Pulmonology
7.7.1. Pulmonology Market, 2018 – 2030 (USD Billion)
7.8. Gastroenterology
7.8.1. Gastroenterology Market, 2018 – 2030 (USD Billion)
7.9. Nephrology
7.9.1. Nephrology Market, 2018 – 2030 (USD Billion)
7.10. Ophthalmology
7.10.1. Ophthalmology Market, 2018 – 2030 (USD Billion)
7.11. Others
7.11.1. Others Market, 2018 – 2030 (USD Billion)
Chapter 8. Type of Drug Business Analysis
8.1. Active Pharmaceutical Ingredients Market: Type of Drug Movement Analysis
8.2. Prescription
8.2.1. Prescription Market, 2018 – 2030 (USD Billion)
8.2.1.1. OTC
8.2.1.2. OTC Market, 2018 – 2030 (USD Billion)
Chapter 9. Regional Business Analysis
9.1. Active Pharmaceutical Ingredients Market Share By Region, 2023 & 2030
9.2. North America
9.2.1. North America Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Regulatory Framework
9.2.2.5. Reimbursement Scenario
9.2.2.6. U.S. Active pharmaceutical ingredients market, 2018 – 2030 (USD MILLION)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Reimbursement Scenario
9.2.3.6. Canada Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3. Europe
9.3.1. Europe Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.2. Germany
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. Reimbursement Scenario
9.3.2.6. Germany Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.3. UK
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Reimbursement Scenario
9.3.3.6. UK Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Reimbursement Scenario
9.3.4.6. France Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Reimbursement Scenario
9.3.5.6. Italy Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Reimbursement Scenario
9.3.6.6. Spain Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Reimbursement Scenario
9.3.7.6. Denmark Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Reimbursement Scenario
9.3.8.6. Sweden Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Reimbursement Scenario
9.3.9.6. Norway Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.4. Asia Pacific
9.4.1. Asia Pacific Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. Reimbursement Scenario
9.4.2.6. Japan Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Reimbursement Scenario
9.4.3.6. China Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. Reimbursement Scenario
9.4.4.6. India Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Reimbursement Scenario
9.4.5.6. South Korea Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Reimbursement Scenario
9.4.6.6. Australia Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Reimbursement Scenario
9.4.7.6. Thailand Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.5. Latin America
9.5.1. Latin America Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Reimbursement Scenario
9.5.2.6. Brazil Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Reimbursement Scenario
9.5.3.6. Mexico Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Reimbursement Scenario
9.5.4.6. Argentina Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.6. MEA
9.6.1. MEA Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Reimbursement Scenario
9.6.2.6. South Africa Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Reimbursement Scenario
9.6.3.6. Saudi Arabia Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Reimbursement Scenario
9.6.4.6. UAE Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Reimbursement Scenario
9.6.5.6. Kuwait Active pharmaceutical ingredients market, 2018 – 2030 (USD Billion)
Chapter 10. Competitive Landscape
10.1. Participant’s overview
10.2. Financial performance
10.3. Participant categorization
10.3.1. Market Leaders
10.3.2. Active Pharmaceutical Ingredients Market Share Analysis, 2023
10.3.3. Company Profiles
10.3.3.1. Dr. Reddy’s Laboratories Ltd.
10.3.3.1.1. Company Overview
10.3.3.1.2. Financial Performance
10.3.3.1.3. Product Benchmarking
10.3.3.1.4. Strategic Initiatives
10.3.3.2. Sun Pharmaceutical Industries Ltd.
10.3.3.2.1. Company Overview
10.3.3.2.2. Financial Performance
10.3.3.2.3. Product Benchmarking
10.3.3.2.4. Strategic Initiatives
10.3.3.3. Teva Pharmaceutical Industries Ltd.
10.3.3.3.1. Company Overview
10.3.3.3.2. Financial Performance
10.3.3.3.3. Product Benchmarking
10.3.3.3.4. Strategic Initiatives
10.3.3.4. Cipla Inc.
10.3.3.4.1. Company Overview
10.3.3.4.2. Financial Performance
10.3.3.4.3. Product Benchmarking
10.3.3.4.4. Strategic Initiatives
10.3.3.5. AbbVie Inc.
10.3.3.5.1. Company Overview
10.3.3.5.2. Financial Performance
10.3.3.5.3. Product Benchmarking
10.3.3.5.4. Strategic Initiatives
10.3.3.6. Aurobindo Pharma
10.3.3.6.1. Company Overview
10.3.3.6.2. Financial Performance
10.3.3.6.3. Product Benchmarking
10.3.3.6.4. Strategic Initiatives
10.3.3.7. Sandoz International GmbH (Novartis AG)
10.3.3.7.1. Company Overview
10.3.3.7.2. Financial Performance
10.3.3.7.3. Product Benchmarking
10.3.3.7.4. Strategic Initiatives
10.3.3.8. Viatris Inc.
10.3.3.8.1. Company Overview
10.3.3.8.2. Financial Performance
10.3.3.8.3. Product Benchmarking
10.3.3.8.4. Strategic Initiatives
10.3.3.9. Fresenius Kabi AG
10.3.3.9.1. Company Overview
10.3.3.9.2. Financial Performance
10.3.3.9.3. Product Benchmarking
10.3.3.9.4. Strategic Initiatives
10.3.3.10. STADA Arzneimittel AG
10.3.3.10.1. Company Overview
10.3.3.10.2. Financial Performance
10.3.3.10.3. Product Benchmarking
10.3.3.10.4. Strategic Initiatives
10.3.4. Strategy Mapping
10.3.4.1. Expansion
10.3.4.2. Acquisition
10.3.4.3. Collaborations
10.3.4.4. Disease Type/Drug Class Launch
10.3.4.5. Partnerships
10.3.4.6. Others

List of Tables

Table 1 List of Tables
Table 2 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
Table 3 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 4 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 5 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 6 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 7 Global Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 8 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 9 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 10 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 11 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 12 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 13 North America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 18 U.S. Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 19 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 20 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 21 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 22 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 23 Canada Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 24 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 25 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 26 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 27 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 28 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 29 Europe Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 30 UK Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 31 UK Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 32 UK Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 33 UK Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 34 UK Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 35 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 36 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 37 Germany Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 38 Germany Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 39 Germany Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 40 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 41 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 42 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 43 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 44 France Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 45 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 46 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 47 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 48 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 49 Italy Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 50 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 51 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 52 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 53 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 54 Spain Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 55 Denmark Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 56 Denmark Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 57 Denmark Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 58 Denmark Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 59 Denmark Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 60 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 61 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 62 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 63 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 64 Sweden Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 65 Norway Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 66 Norway Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 67 Norway Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 68 Norway Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 69 Norway Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 70 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 71 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 72 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 73 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 74 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 75 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 76 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 77 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 78 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 79 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 80 Japan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 81 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 82 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 83 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 84 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 85 China Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 86 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 87 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 88 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 89 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 90 India Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 91 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 92 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 93 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 94 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 95 Australia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 96 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 97 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 98 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 99 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 100 South Korea Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 101 Thailand Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 102 Thailand Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 103 Thailand Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 104 Thailand Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 105 Thailand Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 106 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 107 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 108 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 109 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 110 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 111 Latin America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 112 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 113 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 114 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 115 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 116 Brazil Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 117 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 118 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 119 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 120 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 121 Mexico Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 122 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 123 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 124 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 125 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 126 Argentina Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 127 Middle East & Africa Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 128 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 129 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 130 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 131 Middle East & Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 132 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 133 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 134 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 135 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 136 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 137 South Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 138 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 139 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 140 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 141 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 142 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 143 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 144 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 145 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 146 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 147 UAE Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 148 Kuwait Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 149 Kuwait Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 150 Kuwait Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 151 Kuwait Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 152 Kuwait Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)

※본 조사보고서 [세계의 원료 의약품 (API) 시장 2024-2030 : 합성 유형별 (바이오, 합성), 제조업체 유형별 (자체 생산, 외부 판매), 종류별, 용도별, 의약품 유형별, 지역별] (코드 : GRV24JAN159) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 원료 의약품 (API) 시장 2024-2030 : 합성 유형별 (바이오, 합성), 제조업체 유형별 (자체 생산, 외부 판매), 종류별, 용도별, 의약품 유형별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

세계의 원료 의약품 (API) 시장 2024-2030 : 합성 유형별 (바이오, 합성),…

[이하, 관련 보고서 소개]

세계의 펩티드 마이크로어레이 시장 (2023~2030) : 질환 진단, 단백질 기능 분석
GRV23MA024 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 펩티드 마이크로어레이 시장 규모가 2023년부터 2030년 사이에 연평균 4.51% 성장하여, 2030년에는 1,133.5백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 펩티드 마이크로어레이 시장을...Peptide Microarray Market Growth & Trends The global peptide microarray market size is expected to reach USD 1,133.5 million by 2030, registering a CAGR of 4.51% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to witness a stable growth rate...

세계의 미생물 API 시장 2023-2030 : 호스별 (포유류, 박테리아, 곰팡이), 유형별 (항체, 펩타이드, 단백질), 부위별, 분자별, 최종 용도별, 지역별
GRV24JAN164 / Grand View Research / 2023년 11월 / 글로벌 미생물 API 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 미생물 API 시장 규모는 2030년까지 961억1000만 달러에 달할 것으로 예상되며, 2023년에서 2030년까지 6.66%의 CAGR을 기록할 것으로...1. 조사 방법 및 범위 2. 개요 3. 세계의 미생물 API 시장 변수/동향/범위 4. 세계의 미생물 API 시장 규모 : 호스트별 비즈니스 분석 5. 세계의 미생물 API 시장 규모 : 유형별 비즈니스 분석 6. 세계의 미생물 API 시장 규모 : 사이트별 비즈니스 분석 7. 세계의 미생물 API 시장 규모 :...

세계의 라벨 프리 어레이 시스템 시장 (2023~2030) : 표면 플라즈몬 공명, 생체층 간섭, 세포 유전 분광
GRV23MR110 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 라벨 프리 어레이 시스템 시장 규모가 2023년부터 2030년 사이에 CAGR 7.42% 증가하여, 2030년에는 799.59백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는...Label-free Array System Market Growth & Trends The global label-free array system market size is expected to reach USD 799.59 million by 2030, expanding at a CAGR of 7.42% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial...

세계의 맞춤형 항체 시장 (2023~2030) : 단클론 항체, 폴리클로날 항체, 재조합 항체, 기타
GRV23MR076 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 맞춤형 항체 시장 규모가 2023년부터 2030년 사이에 CAGR 9.7% 증가하여, 2030년에는 301.7백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는 세계의 맞춤형...Custom Antibody Market Growth & Trends The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during...

세계의 ELISA 분석기 시장 (2023~2030) : 광학 필터식 ELISA 분석기, 광학 격자식 ELISA 분석기
GRV23MR090 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 ELISA 분석기 시장 규모가 2023년부터 2030년 사이에 CAGR 3.7% 증가하여, 2030년에는 754.38백만달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 ELISA...ELISA Analyzers Market Growth & Trends The global ELISA analyzer market size is expected to reach USD 754.38 million by 2030 expanding at a CAGR of 3.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a lucrative growth...